Amneal to Participate at Upcoming Investor Conferences
November 23 2022 - 8:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today
announced that the management team will attend the following
investor conferences:
Piper Sandler 34th Annual Healthcare Conference December
1, 2022 New York, New York
41st Annual J.P. Morgan Healthcare Conference January 10,
2023 San Francisco, California Presentation – 2:15 PM Pacific
Time
A live webcast of the J.P. Morgan Healthcare conference
presentation will be accessible through the Investor Relations
section of the Company's website at https://investors.amneal.com. A
replay of the webcast will be posted shortly after the presentation
and will be available for 90 days following the event.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is a fully integrated essential medicines company.
We make healthy possible through the development, manufacturing,
and distribution of generic and specialty pharmaceuticals,
primarily within the United States. The Company has a diverse
portfolio of over 250 products in its Generics segment and is
expanding across a broad range of complex products and therapeutic
areas, including injectables and biosimilars. In its Specialty
segment, Amneal has a growing portfolio of branded pharmaceutical
products focused primarily on central nervous system and endocrine
disorders, with a pipeline focused on unmet needs. Through its
AvKARE segment, the Company is a distributor of pharmaceuticals and
other products for the U.S. federal government, retail, and
institutional markets. For more, please visit www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221123005119/en/
Anthony DiMeo Head of Investor Relations
Anthony.DiMeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Sep 2023 to Sep 2024